ACRS
Aclaris Therapeutics Inc
Price:  
3.54 
USD
Volume:  
897,828.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Aclaris Relative Valuation

-391.6%
Upside

As of 2026-03-17, the Relative Valuation of Aclaris Therapeutics Inc (ACRS) is (10.32) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.54 USD, the upside of Aclaris Therapeutics Inc based on Relative Valuation is -391.6%.

The range of the Relative Valuation is (9.87) - (11.15) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 16.5x - 19.2x 18.0x
Forward P/E multiples 14.7x - 18.6x 16.4x
Fair Price (9.87) - (11.15) (10.32)
Upside -378.9% - -414.8% -391.6%
3.54 USD
Stock Price
(10.32) USD
Fair Price

Aclaris Relative Valuation - Historical P/E Data

Date P/E
2026-03-13 -5.91
2026-03-12 -5.86
2026-03-11 -6.01
2026-03-10 -6.12
2026-03-09 -5.66
2026-03-06 -5.11
2026-03-05 -5.21
2026-03-04 -5.17
2026-03-03 -5.07
2026-03-02 -5.09
2026-02-27 -4.79
2026-02-26 -5.22
2026-02-25 -5.52
2026-02-24 -5.61
2026-02-23 -5.42
2026-02-20 -5.41
2026-02-19 -5.39
2026-02-18 -5.29
2026-02-17 -5.44
2026-02-13 -5.32
2026-02-12 -5.61
2026-02-11 -5.66
2026-02-10 -6.09
2026-02-09 -6.16
2026-02-06 -5.96
2026-02-05 -5.66
2026-02-04 -5.91
2026-02-03 -5.79
2026-02-02 -6.02
2026-01-30 -5.86
2026-01-29 -5.72
2026-01-28 -5.86
2026-01-27 -6.46
2026-01-26 -6.38
2026-01-23 -7.51
2026-01-22 -7.56
2026-01-21 -7.38
2026-01-20 -7.39
2026-01-16 -4.37
2026-01-15 -4.46
2026-01-14 -4.57
2026-01-13 -4.52
2026-01-12 -4.44
2026-01-09 -4.41
2026-01-08 -4.47
2026-01-07 -4.47
2026-01-06 -4.42
2026-01-05 -4.42
2026-01-02 -4.81
2025-12-31 -5.02